The Eaton-Lambert syndrome in ocular myasthenia gravis.
D001984:Bronchial Neoplasms / Q000175:diagnosis / Q000209:etiology*; D002277:Carcinoma / Q000209:etiology; D003937:Diagnosis, Differential; D004491:Edrophonium; D004558:Electric Stimulation; D004576:Electromyography; D005942:Gluconates; D006146:Guanidines / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009135:Muscular Diseases / Q000175:diagnosis / Q000209:etiology*; D009157:Myasthenia Gravis / Q000150:complications* / Q000175:diagnosis / Q000188:drug therapy / Q000503:physiopathology; D009388:Neostigmine / Q000627:therapeutic use; D009431:Neural Conduction; D009801:Oculomotor Muscles / Q000503:physiopathology; D009886:Ophthalmoplegia / Q000175:diagnosis / Q000188:drug therapy / Q000209:etiology*; D010525:Peripheral Nerves / Q000503:physiopathology; D011729:Pyridostigmine Bromide / Q000627:therapeutic use
D005942:Gluconates; D006146:Guanidines; D009388:Neostigmine; D004491:Edrophonium; D011729:Pyridostigmine Bromide